BBV Review

Blood Borne Virus Review for Healthcare Professionals

[BBV Review @BBVReview]

@DrLoomba @JVLazarus There are more advanced ML & AI methods including LIVERFASt a product of Fibronostics which has been used in diagnosis of over 70K patients so far. https://t.co/EDbOGiky9h

[Henry E. Chang @HenryEChang]

#HCV treatment in 2020: How to translate highly effective
therapies into elimination strategies→https://t.co/gvgyBRaitj via Drs. Omar Alshuwayk & @PaulYKwo @Stanford_GI @StanfordMed @taslorgtr #HepC #HepatitisC #HepAware2020 #HepFreeNYC

[Henry E. Chang @HenryEChang]

Sustainable Development Goals for #HBV elimination in South Africa: challenges, progress & the road ahead→https://t.co/TCuJxN2Bq6 via Drs. @TongaiMaponga, Chikezie Nwankwo & @pippa_matt @SabinetJournals #HepB #HepatitisB #HCC #SDG 🇿🇦

[Graham Cooke @grahamscooke]

Two helpful pieces on HCV reinfection from @GregDore2 @ProfJohnDillon at a time when we're trying to get access to retreatment in England https://t.co/6wErI3asHV https://t.co/m2aZ387LBK

[Henry E. Chang @HenryEChang]

Biological basis for functional cure of chronic #hepatitis B→https://t.co/vGzHbrJkbs via Drs. MG Martinez, Barbara Testoni & Fabien Zoulim @CHUdeLyon @UniversiteLyon #HBV #HepB #HepatitisB

[Henry E. Chang @HenryEChang]

Prevalence, incidence, & outcome of non-alcoholic fatty liver disease in #Asia, 1999-2019: a systematic review & meta-analysis→https://t.co/WNLtACYxAp via @LancetGastroHep

[Comment] The increasing clinical burden of #NAFLD in Asia→https://t.co/p3po5pPpow #NASH #ILC2019

[Gottfried Hirnschall @GHirnschall]

We have positive news on #HepB on children under 5 born w #HBV declining from 1.3% in 2015 to 0.8% in 2017. However, for the 257 mln living w/ chronic infection, testing, treatment access remains extremely low. #ILC2019.

[Rick Dunn @RickJDunn]

Cost of DAAs not the barrier to elimination it once was per @MargaretHellard. Financing the cost of diagnostics is key. We agree! We have scalable model @GPRO_Fund and will test this year via #UHEP. 250K to be screened; 20K treated. @CDAFound #ILC2019 @Homie_Razavi #NOhep

[Gottfried Hirnschall @GHirnschall]

Our @AnnetteWHO is at #HR19 where we will be launching a new policy brief on "access to #hepC testing and treatment for people who inject drugs #PWID and people in prisons #PIP - a global perspective". See publication https://t.co/jFgJ63XXdL @rbaggaley @NTunga .@HRInews

[Henry E. Chang @HenryEChang]

Taiwan commits to eliminating #hepatitis C in 2025→https://t.co/saY75tJ2Ar via Dr. Ding-Shinn Chen @TheLancetInfDis #HCV #HepC #HepatitisC #Taiwan #GHS2020 #HealthForAll 🇹🇼

[Henry E. Chang @HenryEChang]

#BreakingNews 🔥 #ILC2019 abstracts, including some late-breaker abstracts, are now available online→https://t.co/qZbK1q0p6G

Preview this "gigantic mosaic of new knowledge" (per @tomhemmingk) & start planning your attendance now by having a look at online programme planner.

[Heidar Sharafi @HeidarSharafi]

Our recent study on using #HCV rapid test for screening in prison. The screening with #RDT is feasible and reliable however the quality of testing by the end-users is the matter. You can find it at https://t.co/UP9kMa923W

[Henry E. Chang @HenryEChang]

Routine screening for #hepatitis C in #MSM on #HIV #PrEP→https://t.co/BpjCMSWO2H via Drs. Douglas Krakower & Kenneth Mayer @BIDMChealth @FenwayHealth @DeptPopMed @NatRevUrol #HCV #HepC #HepatitisC

[Henry E. Chang @HenryEChang]

Challenges of eliminating mother-to-child transmission of #HIV, #syphilis and #hepatitis B in #China: a cross sectional survey→https://t.co/fLjoZMSel8 via @TheLancet #PosterAbstract #AIDS #HBV #HepB #HepatitisB #PMTCT #HealthForAll 🇨🇳

[BBV Review @BBVReview]

InTec Products Inc. is donating 50,000 #HIV #RDTs for European #testing ETW week.

[Hep B Foundation @HepBFoundation]

Questions about treatments for #hepatitis B? Check out our revised fact sheet. #hepB #HBV #hepatitisB Read, print and use it at your next event! https://t.co/FX9V0zJqr5

[The Liver Dude @MichaelHenegha8]

Jean Michel Pawlotski discussing Hepatitis C Virus elimination strategies for HCV. Focus, vision and drive. @LiverTrust @basl_events @EASLedu

[HepCure @hepcure]

On 10/2 @ 4:30 PM EST, @SarahJBlach of @CDAFound @GPRO_Fund will present on "Global Strategies for Reducing #HepatitisC Transmission Through Treatment and #HarmReduction." Learn more here ... https://t.co/hHXQjANlkS
#NOHep #HepC #HCV

[Raymond Schinazi @drugbuster21]

At the 2018HBV Molecular Biology meeting in Taormina, Sicily, with the organizers Teresa Pollicino and Michael Bouchard. Gorgeous venue for over 600 delegates with lots of young scientists